EBioMedicine (Nov 2015)

Mimecan, a Hormone Abundantly Expressed in Adipose Tissue, Reduced Food Intake Independently of Leptin Signaling

  • Huang-Ming Cao,
  • Xiao-Ping Ye,
  • Jun-Hua Ma,
  • He Jiang,
  • Sheng-Xian Li,
  • Rong-Ying Li,
  • Xue-Song Li,
  • Cui-Cui Guo,
  • Zhi-Quan Wang,
  • Ming Zhan,
  • Chun-Lin Zuo,
  • Chun-Ming Pan,
  • Shuang-Xia Zhao,
  • Cui-Xia Zheng,
  • Huai-Dong Song

DOI
https://doi.org/10.1016/j.ebiom.2015.09.044
Journal volume & issue
Vol. 2, no. 11
pp. 1718 – 1724

Abstract

Read online

Adipokines such as leptin play important roles in the regulation of energy metabolism, particularly in the control of appetite. Here, we describe a hormone, mimecan, which is abundantly expressed in adipose tissue. Mimecan was observed to inhibit food intake and reduce body weight in mice. Intraperitoneal injection of a mimecan-maltose binding protein (-MBP) complex inhibited food intake in C57BL/6J mice, which was attenuated by pretreatment with polyclonal antibody against mimecan. Notably, mimecan-MBP also induced anorexia in Ay/a and db/db mice. Furthermore, the expression of interleukin (IL)-1β and IL-6 was up-regulated in the hypothalamus by mimecan-MBP, as well as in N9 microglia cells by recombinant mouse mimecan. Taken together, the results suggest that mimecan is a satiety hormone in adipose tissue, and that mimecan inhibits food intake independently of leptin signaling by inducing IL-1β and IL-6 expression in the hypothalamus.

Keywords